Gregory Bradley's most recent trade in Petros Pharmaceuticals Inc was a trade of 40,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,050 | 0 | - | - | Restricted Stock Units | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2023 | 6,050 | 8,314 | - | - | Common Stock | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2023 | 39,000 | 39,000 | - | - | Stock Option (Right to Buy) | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 2,264 | 2,264 | - | - | Common Stock | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2023 | 2,264 | 0 | - | - | Restricted Stock Units | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2022 | 60,505 | 60,505 | - | - | Restricted Stock Units | |
| Petros Pharmaceuticals Inc | Gregory Bradley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2021 | 50,000 | 50,000 | - | - | Stock Options (right to buy) |